Related Experiment Videos
Cyclosporine A (CyA)-induced decrease of serum gonadotropin levels in a case of Klinefelter's syndrome
1First Department of Internal Medicine, School of Medicine, Kanazawa University, Japan.
Nihon Naibunpi Gakkai Zasshi
|January 20, 1991
Summary
This case study shows that cyclosporine A (CyA) treatment can lower gonadotropin levels in men with Klinefelter syndrome and focal glomerulosclerosis. The decrease in luteinizing hormone (LH) and follicle-stimulating hormone (FSH) persisted after stopping CyA.
Area of Science:
- Endocrinology
- Nephrology
- Genetics
Background:
- Klinefelter syndrome (47,XXY) is a genetic condition associated with hypogonadism.
- Focal glomerulosclerosis (FGS) is a kidney disease often requiring immunosuppressive therapy.
- Cyclosporine A (CyA) is an immunosuppressant used to treat various conditions, including FGS.
Observation:
- A 38-year-old man with Klinefelter syndrome and FGS received CyA treatment.
- The patient exhibited high baseline luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels.
- Physical examination revealed characteristics consistent with Klinefelter syndrome, including small testes.
Findings:
- CyA treatment led to a significant decrease in serum LH and FSH levels.
- This reduction in gonadotropins persisted for at least six weeks after CyA cessation.
- Serum testosterone levels remained low-normal without significant changes during treatment.
Implications:
- CyA may suppress pituitary gonadotropin secretion in individuals with Klinefelter syndrome.
- This finding is relevant for managing patients with both Klinefelter syndrome and kidney diseases requiring immunosuppression.
- Further research is needed to understand the long-term effects and mechanisms of CyA on the hypothalamic-pituitary-gonadal axis.